Bioinformatics and systems biology analysis revealed PMID26394986-Compound-10 as potential repurposable drug against covid-19

References

• Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1–2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001
   Google Scholar
• Adhami, M., Motie Ghader, H., Haghdoost, A. A., Afshar, R. M., & Sadeghi, B. (2020). Gene co-expression network approach for predicting prognostic microRNA biomarkers in different subtypes of breast cancer. Genomics, 112(1), 135–143. https://doi.org/10.1016/j.ygeno.2019.01.010
   PubMed Web of Science ®Google Scholar
• Ahmed, F. F., Reza, M. S., Sarker, M. S., Islam, M. S., Mosharaf, M. P., Hasan, S., & Mollah, M. N. H. (2022). Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches. PLOS One, 17(4), e0266124. https://doi.org/10.1371/journal.pone.0266124
   PubMed Web of Science ®Google Scholar
• Ahmed, S. F., Quadeer, A. A., & McKay, M. R. (2020). Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies. Viruses, 12, 254. https://doi.org/10.3390/v12030254
   PubMed Web of Science ®Google Scholar
• Arantes, P. R., Polêto, M. D., Pedebos, C., & Ligabue-Braun, R. (2021). Making it rain: Cloud-based molecular simulations for everyone. Journal of Chemical Information and Modeling, 61(10), 4852–4856. https://doi.org/10.1021/acs.jcim.1c00998
   PubMed Web of Science ®Google Scholar
• Arshad, S., Kilgore, P., Chaudhry, Z. S., Jacobsen, G., Wang, D. D., Huitsing, K., Brar, I., Alangaden, G. J., Ramesh, M. S., McKinnon, J. E., O'Neill, W., & Zervos, M. (2020). Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19. International Journal of Infectious Diseases, 97, 396–403. https://doi.org/10.1016/j.ijid.2020.06.099
   PubMed Web of Science ®Google Scholar
• Asad, D., & Shuja, S. H. (2021). Role of folate, cobalamin, and probiotics in COVID-19 disease management. Drug Design, Development and Therapy, 15, 3709–3710. https://doi.org/10.2147/DDDT.S333295
   PubMed Web of Science ®Google Scholar
• Auwal, M. R., Rahman, M. R., Gov, E., Shahjaman, M., & Moni, M. A. (2021). Bioinformatics and machine learning approach identifies potential drug targets and pathways in COVID-19. Briefings in Bioinformatics, 22, 1–13.
   PubMed Web of Science ®Google Scholar
• Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., Lopez de Castilla, D., Finberg, R. W., Dierberg, K., Tapson, V., Hsieh, L., Patterson, T. F., Paredes, R., Sweeney, D. A., Short, W. R., … Lane, H. C. (2020). Remdesivir for the treatment of Covid-19 – Final report. The New England Journal of Medicine, 383(19), 1813–1826. https://doi.org/10.1056/NEJMoa2007764
   PubMed Web of Science ®Google Scholar
• Bhaskar, S., Sinha, A., Banach, M., Mittoo, S., Weissert, R., Kass, J. S., Rajagopal, S., Pai, A. R., & Kutty, S. (2020). Cytokine storm in COVID-19—immunopathological mechanisms, clinical considerations, and therapeutic approaches: The REPROGRAM consortium position paper. Frontiers in Immunology, 11, 1648. https://doi.org/10.3389/fimmu.2020.01648
   PubMed Web of Science ®Google Scholar
• Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., Li, X., Xia, J., Chen, N., Xiang, J., Yu, T., Bai, T., Xie, X., Zhang, L., Li, C., … Wang, C. (2020). A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. The New England Journal of Medicine, 382(19), 1787–1799. https://doi.org/10.1056/NEJMoa2001282
   PubMed Web of Science ®Google Scholar
• Chan, A. T., Giovannucci, E. L., Meyerhardt, J. A., Schernhammer, E. S., Curhan, G. C., & Fuchs, C. S. (2005). Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA, 294(8), 914–923. https://doi.org/10.1001/jama.294.8.914
   PubMed Web of Science ®Google Scholar
• Chatterjee, B., & Thakur, S. S. (2020). ACE2 as a potential therapeutic target for pandemic COVID-19. RSC Advances, 10(65), 39808–39813. https://doi.org/10.1039/d0ra08228g
   PubMed Web of Science ®Google Scholar
• Cheemarla, N. R., Watkins, T. A., Mihaylova, V. T., Wang, B., Zhao, D., Wang, G., Landry, M. L., & Foxman, E. F. (2021). Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics. The Journal of Experimental Medicine, 218(8), e20210583. https://doi.org/10.1084/jem.20210583
   Google Scholar
• Chen, X., Ji, Z. L., & Chen, Y. Z. (2002). TTD: Therapeutic target database. Nucleic Acids Research, 30(1), 412–415. https://doi.org/10.1093/nar/30.1.412
   PubMed Web of Science ®Google Scholar
• Chillistone, S., &Hardman, J. G. (2017). Factors affecting drug absorption and distribution. Anaesthesia & Intensive Care Medicine, 18(7), 335–339. https://doi.org/10.1016/j.mpaic.2017.04.007
   Google Scholar
• Chin, C.-H., Chen, S.-H., Wu, H.-H., Ho, C.-W., Ko, M.-T., & Lin, C.-Y. (2014). cytoHubba: Identifying hub objects and sub-networks from complex interactome. BMC Systems Biology, 8(Suppl 4), S11. https://doi.org/10.1186/1752-0509-8-S4-S11
   PubMed Web of Science ®Google Scholar
• Cp, O., & Ms, L. (2018, July 25). Bromocriptine for type 2 diabetes mellitus. Cochrane Database Systematic Reviews, 2018(7), CD010319.
   Google Scholar
• Daina, A.,Michielin, O., &Zoete, V. (2017). SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717.https://doi.org/10.1038/srep42717. PMC: 28256516
   PubMed Web of Science ®Google Scholar
• Danesi, R., Falcone, A., Conte, P. F., & Del Tacca, M. (1998). Pharmacokinetic optimisation of the treatment of cancer with high dose zidovudine. Clinical Pharmacokinetics, 34(2), 173–180. https://doi.org/10.2165/00003088-199834020-00005
   PubMed Web of Science ®Google Scholar
• Dhangadamajhi, G., & Rout, R. (2021). Association of TLR3 functional variant (rs3775291) with COVID-19 susceptibility and death: A population-scale study. Human Cell, 34(3), 1025–1027. https://doi.org/10.1007/s13577-021-00510-6
   PubMed Web of Science ®Google Scholar
• Dwivedy, A., Mariadasse, R., Ahmad, M., Chakraborty, S., Kar, D., Tiwari, S., Bhattacharyya, S., Sonar, S., Mani, S., Tailor, P., Majumdar, T., Jeyakanthan, J., & Biswal, B. K. (2021). Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic target against SARS-CoV-2. PLOS Computational Biology, 17(9), e1009384. https://doi.org/10.1371/journal.pcbi.1009384
   PubMed Web of Science ®Google Scholar
• El-Hachem, N., Eid, E., Nemer, G., Dbaibo, G., Abbas, O., Rubeiz, N., Zeineldine, S., Matar, G. M., Bikorimana, J.-P., Shammaa, R., Haibe-Kains, B., Kurban, M., & Rafei, M. (2020). Integrative transcriptome analyses empower the anti-COVID-19 drug arsenal. iScience, 23(11), 101697. https://doi.org/10.1016/j.isci.2020.101697
   PubMed Web of Science ®Google Scholar
• Egan, W. J., Merz, K. M., & Baldwin, J. J. (2000). Prediction of drug absorption using multivariate statistics. Journal of Medicinal Chemistry, 43(21), 3867–3877. https://doi.org/10.1021/jm000292e
   PubMed Web of Science ®Google Scholar
• Frankish, A., Diekhans, M., Ferreira, A.-M., Johnson, R., Jungreis, I., Loveland, J., Mudge, J. M., Sisu, C., Wright, J., Armstrong, J., Barnes, I., Berry, A., Bignell, A., Carbonell Sala, S., Chrast, J., Cunningham, F., Di Domenico, T., Donaldson, S., Fiddes, I. T., … Flicek, P. (2019). GENCODE reference annotation for the human and mouse genomes. Nucleic Acids Research, 47(D1), D766–D773. https://doi.org/10.1093/nar/gky955
   PubMed Web of Science ®Google Scholar
• Freitas, R. S., Crum, T. F., & Parvatiyar, K. (2021). SARS-CoV-2 spike antagonizes innate antiviral immunity by targeting interferon regulatory factor 3. Frontiers in Cellular and Infection Microbiology, 11, 789462. https://doi.org/10.3389/fcimb.2021.789462
   PubMed Web of Science ®Google Scholar
• Gao, J., Tian, Z., & Yang, X. (2020). Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Bioscience Trends, 14(1), 72–73. https://doi.org/10.5582/bst.2020.01047
   PubMed Web of Science ®Google Scholar
• Gene Ontology C (2008). The gene ontology project in 2008. Nucleic Acids Research, 36, D440–D444.
   PubMed Web of Science ®Google Scholar
• Ghahremanpour, M. M., Tirado-Rives, J., Deshmukh, M., Ippolito, J. A., Zhang, C.-H., Cabeza de Vaca, I., Liosi, M.-E., Anderson, K. S., & Jorgensen, W. L. (2020). Identification of 14 known drugs as inhibitors of the main protease of SARS-CoV-2. ACS Medicinal Chemistry Letters, 11(12), 2526–2533. https://doi.org/10.1021/acsmedchemlett.0c00521
   PubMed Web of Science ®Google Scholar
• Ghofrani, H. A., Osterloh, I. H., & Grimminger, F. (2006). Sildenafil: From angina to erectile dysfunction to pulmonary hypertension and beyond. Nature Reviews. Drug Discovery, 5(8), 689–702. https://doi.org/10.1038/nrd2030
   PubMed Web of Science ®Google Scholar
• Hoffmann, M., Hofmann-Winkler, H., Smith, J. C., Krüger, N., Arora, P., Sørensen, L. K., Søgaard, O. S., Hasselstrøm, J. B., Winkler, M., Hempel, T., Raich, L., Olsson, S., Danov, O., Jonigk, D., Yamazoe, T., Yamatsuta, K., Mizuno, H., Ludwig, S., Noé, F., … Pöhlmann, S. (2021). Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity. EBioMedicine, 65, 103255. https://doi.org/10.1016/j.ebiom.2021.103255
   PubMed Web of Science ®Google Scholar
• Grosset, K. A., & Grosset, D. G. (2004). Prescribed drugs and neurological complications. Journal of Neurology, Neurosurgery, and Psychiatry, 75(Suppl 3), iii2–iii8. https://doi.org/10.1136/jnnp.2004.045757
   PubMedGoogle Scholar
• Guan, L.,Yang, H.,Cai, Y.,Sun, L.,Di, P.,Li, W.,Liu, G., &Tang, Y. (2019). ADMET-score- a comprehensive scoring function for evaluation of chemical drug-likeness. MedChemComm, 10(1), 148–157. https://doi.org/10.1039/c8md00472b 30774861
   PubMed Web of Science ®Google Scholar
• Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., … Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223), 497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols, 4(1), 44–57. https://doi.org/10.1038/nprot.2008.211
   PubMed Web of Science ®Google Scholar
• Imami, A. S., O'Donovan, S. M., Creeden, J. F., Wu, X., Eby, H., McCullumsmith, C. B., Uvnäs-Moberg, K., McCullumsmith, R. E., & Andari, E. (2020). Oxytocin’s anti-inflammatory and proimmune functions in COVID-19: A transcriptomic signature-based approach. Physiological Genomics, 52(9), 401–407. https://doi.org/10.1152/physiolgenomics.00095.2020
   PubMed Web of Science ®Google Scholar
• Infante, M., Ricordi, C., Alejandro, R., Caprio, M., & Fabbri, A. (2021). Hydroxychloroquine in the COVID-19 pandemic era: In pursuit of a rational use for prophylaxis of SARS-CoV-2 infection. Expert Review of Anti-Infective Therapy, 19(1), 5–16. https://doi.org/10.1080/14787210.2020.1799785
   PubMed Web of Science ®Google Scholar
• Iorio, F., Bosotti, R., Scacheri, E., Belcastro, V., Mithbaokar, P., Ferriero, R., Murino, L., Tagliaferri, R., Brunetti-Pierri, N., Isacchi, A., & di Bernardo, D. (2010). Discovery of drug mode of action and drug repositioning from transcriptional responses. Proceedings of the National Academy of Sciences, 107(33), 14621–14626. https://doi.org/10.1073/pnas.1000138107
   PubMed Web of Science ®Google Scholar
• Islam, T., Rahman, M. R., Aydin, B., Beklen, H., Arga, K. Y., & Shahjaman, M. (2020). Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19. European Journal of Pharmacology, 887, 173594.
   PubMed Web of Science ®Google Scholar
• Jamshaid, H., Zahid, F., Din, I. U., Zeb, A., Choi, H. G., Khan, G. M., & Din, F. U. (2020). Diagnostic and treatment strategies for COVID-19. AAPS PharmSciTech, 21(6), 222. https://doi.org/10.1208/s12249-020-01756-3
   PubMed Web of Science ®Google Scholar
• Karami, H., Derakhshani, A., Ghasemigol, M., Fereidouni, M., Moghaddam, E. M., Baradaran, B., Tabrizi, N. J., Najafi, S, Solimando, A. G., March, L. M., Silvestris, N., Summa, S. D., Paradiso, A. V., Racanelli, V., & Safarpour, H. (2021). Weighted gene co-expression network analysis combined with machine learning validation to identify key modules and hub genes associated with SARS-CoV-2 infection. Journal of Clinical Medicine, 10, 3567. https://doi.org/10.3390/jcm10163567
   PubMed Web of Science ®Google Scholar
• Kanehisa, M., & Goto, S. (2000). KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Research, 28(1), 27–30. https://doi.org/10.1093/nar/28.1.27
   PubMed Web of Science ®Google Scholar
• Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B. A., Wang, J., Yu, B., Zhang, J., & Bryant, S. H. (2016). PubChem substance and compound databases. Nucleic Acids Research, 44(D1), D1202–D1213. https://doi.org/10.1093/nar/gkv951
   PubMed Web of Science ®Google Scholar
• König, J.,Glaeser, H.,Keiser, M.,Mandery, K.,Klotz, U., &Fromm, M. F. (2011). Role of organic anion-transporting polypeptides for cellular mesalazine (5-aminosalicylic acid) uptake. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 39(6), 1097–1102. https://doi.org/10.1124/dmd.110.034991 21430235
   PubMed Web of Science ®Google Scholar
• Kouwaki, T., Nishimura, T., Wang, G., & Oshiumi, H. (2021). RIG-I-like receptor-mediated recognition of viral genomic RNA of severe acute respiratory syndrome Coronavirus-2 and viral escape from the host innate immune responses. Frontiers in Immunology, 12, 700926. https://doi.org/10.3389/fimmu.2021.700926
   PubMed Web of Science ®Google Scholar
• Kuleshov, M. V., Jones, M. R., Rouillard, A. D., Fernandez, N. F., Duan, Q., Wang, Z., Koplev, S., Jenkins, S. L., Jagodnik, K. M., Lachmann, A., McDermott, M. G., Monteiro, C. D., Gundersen, G. W., & Ma’ayan, A. (2016). Enrichr: A comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Research, 44(W1), W90–W97. https://doi.org/10.1093/nar/gkw377
   PubMed Web of Science ®Google Scholar
• Kuleshov, M. V., Stein, D. J., Clarke, D. J. B., Kropiwnicki, E., Jagodnik, K. M., Bartal, A., Evangelista, J. E., Hom, J., Cheng, M., Bailey, A., Zhou, A., Ferguson, L. B., Lachmann, A., & Ma’ayan, A. (2020). The COVID-19 drug and gene set library. Patterns, 1(6), 100090. https://doi.org/10.1016/j.patter.2020.100090
   PubMedGoogle Scholar
• Lai, P.-S., Rosa, D. A., Magdy Ali, A., Gómez-Biagi, R. F., Ball, D. P., Shouksmith, A. E., & Gunning, P. T. (2015). A STAT inhibitor patent review: Progress since 2011. Expert Opinion on Therapeutic Patents, 25(12), 1397–1421. https://doi.org/10.1517/13543776.2015.1086749
   PubMed Web of Science ®Google Scholar
• Lambertini, A., Hartrampf, P. E., Higuchi, T., Serfling, S. E., Meybohm, P., Schirbel, A., Buck, A. K., & Werner, R. A. (2022). CXCR4-targeted molecular imaging after severe SARS-Cov-2 infection. European Journal of Nuclear Medicine and Molecular Imaging, 50(1), 228–229. https://doi.org/10.1007/s00259-022-05932-4
   PubMed Web of Science ®Google Scholar
• Lamers, M. M., & Haagmans, B. L. (2022). SARS-CoV-2 pathogenesis. Nature Reviews. Microbiology, 20(5), 270–284. https://doi.org/10.1038/s41579-022-00713-0
   PubMed Web of Science ®Google Scholar
• Lau, Y. L., & Peiris, J. S. M. (2005). Pathogenesis of severe acute respiratory syndrome. Current Opinion in Immunology, 17(4), 404–410. https://doi.org/10.1016/j.coi.2005.05.009
   PubMed Web of Science ®Google Scholar
• Leal, N. S., Yu, Y., Chen, Y., Fedele, G., & Martins, L. M. (2021). Paracetamol is associated with a lower risk of COVID-19 infection and decreased ACE2 protein expression: A retrospective analysis. COVID, 1(1), 218–229. https://doi.org/10.3390/covid1010018
   Google Scholar
• Lee, T.-S., Allen, B. K., Giese, T. J., Guo, Z., Li, P., Lin, C., McGee, T. D., Pearlman, D. A., Radak, B. K., Tao, Y., Tsai, H.-C., Xu, H., Sherman, W., & York, D. M. (2020). Alchemical binding free energy calculations in AMBER20: Advances and best practices for drug discovery. Journal of Chemical Information and Modeling, 60(11), 5595–5623. https://doi.org/10.1021/acs.jcim.0c00613
   PubMed Web of Science ®Google Scholar
• Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., Xing, X., Xiang, N., Wu, Y., Li, C., Chen, Q., Li, D., Liu, T., Zhao, J., Liu, M., … Feng, Z. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. The New England Journal of Medicine, 382(13), 1199–1207. https://doi.org/10.1056/NEJMoa2001316
   PubMed Web of Science ®Google Scholar
• Loli, P., Berselli, M. E., & Tagliaferri, M. (1986). Use of ketoconazole in the treatment of Cushing’s syndrome. The Journal of Clinical Endocrinology and Metabolism, 63(6), 1365–1371. https://doi.org/10.1210/jcem-63-6-1365
   PubMed Web of Science ®Google Scholar
• Manabe, T., Kambayashi, D., Akatsu, H., & Kudo, K. (2021). Favipiravir for the treatment of patients with COVID-19: A systematic review and meta-analysis. BMC Infectious Diseases, 21(1), 489. https://doi.org/10.1186/s12879-021-06164-x
   PubMed Web of Science ®Google Scholar
• Mobley, D. L., Bannan, C. C., Rizzi, A., Bayly, C. I., Chodera, J. D., Lim, V. T., Lim, N. M., Beauchamp, K. A., Slochower, D. R., Shirts, M. R., Gilson, M. K., & Eastman, P. K. (2018). Escaping atom types in force fields using direct chemical perception. Journal of Chemical Theory and Computation, 14(11), 6076–6092. https://doi.org/10.1021/acs.jctc.8b00640
   PubMed Web of Science ®Google Scholar
• Moustaqil, M., Ollivier, E., Chiu, H.-P., Van Tol, S., Rudolffi-Soto, P., Stevens, C., Bhumkar, A., Hunter, D. J. B., Freiberg, A. N., Jacques, D., Lee, B., Sierecki, E., & Gambin, Y. (2021). SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): Implications for disease presentation across species. Emerging Microbes & Infections, 10(1), 178–195. https://doi.org/10.1080/22221751.2020.1870414
   PubMed Web of Science ®Google Scholar
• Mukherjee, T., Behl, T., Sharma, S., Sehgal, A., Singh, S., Sharma, N., Mathew, B., Kaur, J., Kaur, R., Das, M., Aleya, L., & Bungau, S. (2022). Anticipated pharmacological role of Aviptadil on COVID-19. Environmental Science and Pollution Research International, 29(6), 8109–8125. https://doi.org/10.1007/s11356-021-17824-5
   PubMed Web of Science ®Google Scholar
• Nieuwenhuijs-Moeke, G. J., Jainandunsing, J. S., & Struys, M. (2020). Sevoflurane, a sigh of relief in COVID-19? British Journal of Anaesthesia, 125(2), 118–121. https://doi.org/10.1016/j.bja.2020.04.076
   PubMed Web of Science ®Google Scholar
• Peiris, J. S. M., Chu, C. M., Cheng, V. C. C., Chan, K. S., Hung, I. F. N., Poon, L. L. M., Law, K. I., Tang, B. S. F., Hon, T. Y. W., Chan, C. S., Chan, K. H., Ng, J. S. C., Zheng, B. J., Ng, W. L., Lai, R. W. M., Guan, Y., & Yuen, K. Y. (2003). Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study. Lancet, 361(9371), 1767–1772. https://doi.org/10.1016/s0140-6736(03)13412-5
   PubMed Web of Science ®Google Scholar
• Piñero, J., Ramírez-Anguita, J. M., Saüch-Pitarch, J., Ronzano, F., Centeno, E., Sanz, F., & Furlong, L. I. (2020). The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Research, 48(D1), D845–D855. https://doi.org/10.1093/nar/gkz1021
   PubMed Web of Science ®Google Scholar
• Pires, D. E. V.,Blundell, T. L., &Ascher, D. B. (2015). pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures. Journal of Medicinal Chemistry, 58(9), 4066–4072. https://doi.org/10.1021/acs.jmedchem.5b00104 25860834
   PubMed Web of Science ®Google Scholar
• Poulsen, N. N., von Brunn, A., Hornum, M., & Blomberg Jensen, M. (2020). Cyclosporine and COVID-19: Risk or favorable? American Journal of Transplantation, 20(11), 2975–2982. https://doi.org/10.1111/ajt.16250
   PubMed Web of Science ®Google Scholar
• Richardson, P., Griffin, I., Tucker, C., Smith, D., Oechsle, O., Phelan, A., Rawling, M., Savory, E., & Stebbing, J. (2020). Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet, 395(10223), e30–e31. https://doi.org/10.1016/S0140-6736(20)30304-4
   PubMed Web of Science ®Google Scholar
• Rincon-Arevalo, H., Aue, A., Ritter, J., Szelinski, F., Khadzhynov, D., Zickler, D., Stefanski, L., Lino, A. C., Körper, S., Eckardt, K.-U., Schrezenmeier, H., Dörner, T., & Schrezenmeier, E. V. (2022). Altered increase in STAT1 expression and phosphorylation in severe COVID-19. European Journal of Immunology, 52(1), 138–148. https://doi.org/10.1002/eji.202149575
   PubMed Web of Science ®Google Scholar
• Roe, D. R., & Cheatham, T. E III. (2013). PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data. Journal of Chemical Theory and Computation, 9(7), 3084–3095. https://doi.org/10.1021/ct400341p
   PubMed Web of Science ®Google Scholar
• Safran, M., Rosen, N., Twik, M., BarShir, R., Stein, T. I., Dahary, D., et al. (2021). The GeneCards suite. In I. Abugessaisa & T. Kasukawa (Eds.), Practical guide to life science databases (pp. 27–56). Springer Nature Singapore.
   Google Scholar
• Salama, C., Han, J., Yau, L., Reiss, W. G., Kramer, B., Neidhart, J. D., Criner, G. J., Kaplan-Lewis, E., Baden, R., Pandit, L., Cameron, M. L., Garcia-Diaz, J., Chávez, V., Mekebeb-Reuter, M., Lima de Menezes, F., Shah, R., González-Lara, M. F., Assman, B., Freedman, J., & Mohan, S. V. (2021). Tocilizumab in patients hospitalized with Covid-19 pneumonia. The New England Journal of Medicine, 384(1), 20–30. https://doi.org/10.1056/NEJMoa2030340
   PubMed Web of Science ®Google Scholar
• Satarker, S., Tom, A. A., Shaji, R. A., Alosious, A., Luvis, M., & Nampoothiri, M. (2021). JAK-STAT pathway inhibition and their implications in COVID-19 therapy. Postgraduate Medicine, 133, 489–507. https://doi.org/10.1080/00325481.2020.1855921
   PubMed Web of Science ®Google Scholar
• Savitt, A. G., Manimala, S., White, T., Fandaros, M., Yin, W., Duan, H., Xu, X., Geisbrecht, B. V., Rubenstein, D. A., Kaplan, A. P., Peerchke, E. I., & Ghebrehiwet, B. (2021). SARS-CoV-2 exacerbates COVID-19 pathology through activation of the complement and kinin systems, 12, 767347. https://doi.org/10.3389/fimmu.2021.767347
   Google Scholar
• Shuai, K., Ziemiecki, A., Wilks, A. F., Harpur, A. G., Sadowski, H. B., Gilman, M. Z., & Darnell, J. E. (1993). Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature, 366(6455), 580–583. https://doi.org/10.1038/366580a0
   PubMed Web of Science ®Google Scholar
• Spiegel, M., Schneider, K., Weber, F., Weidmann, M., & Hufert, F. T. (2006). Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells. The Journal of General Virology, 87(Pt 7), 1953–1960. https://doi.org/10.1099/vir.0.81624-0
   PubMedGoogle Scholar
• Stebbing, J., Phelan, A., Griffin, I., Tucker, C., Oechsle, O., Smith, D., & Richardson, P. (2020). COVID-19: Combining antiviral and anti-inflammatory treatments. The Lancet. Infectious Diseases, 20(4), 400–402. https://doi.org/10.1016/S1473-3099(20)30132-8
   PubMed Web of Science ®Google Scholar
• Sui, L., Zhao, Y., Wang, W., Wu, P., Wang, Z., Yu, Y., Hou, Z., Tan, G., & Liu, Q. (2021). SARS-CoV-2 membrane protein inhibits type I interferon production through ubiquitin-mediated degradation of TBK1. Frontiers in Immunology, 12, 662989. https://doi.org/10.3389/fimmu.2021.662989
   PubMed Web of Science ®Google Scholar
• Sundar, S., & Chakravarty, J. (2008). Paromomycin in the treatment of leishmaniasis. Expert Opinion on Investigational Drugs, 17(5), 787–794. https://doi.org/10.1517/13543784.17.5.787
   PubMed Web of Science ®Google Scholar
• System TPMG (2022). Version 1.2r3pre. Schrödinger, LLC.
   Google Scholar
• Szklarczyk, D., Gable, A. L., Lyon, D., Junge, A., Wyder, S., Huerta-Cepas, J., Simonovic, M., Doncheva, N. T., Morris, J. H., Bork, P., Jensen, L. J., & Mering, C. v (2019). STRING v11: Protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Research, 47(D1), D607–D613. https://doi.org/10.1093/nar/gky1131
   PubMed Web of Science ®Google Scholar
• Tian, C., Kasavajhala, K., Belfon, K. A. A., Raguette, L., Huang, H., Migues, A. N., Bickel, J., Wang, Y., Pincay, J., Wu, Q., & Simmerling, C. (2020). ff19SB: Amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution. Journal of Chemical Theory and Computation, 16(1), 528–552. https://doi.org/10.1021/acs.jctc.9b00591
   PubMed Web of Science ®Google Scholar
• Tong, S., Su, Y., Yu, Y., Wu, C., Chen, J., Wang, S., & Jiang, J. (2020). Ribavirin therapy for severe COVID-19: A retrospective cohort study. International Journal of Antimicrobial Agents, 56(3), 106114. https://doi.org/10.1016/j.ijantimicag.2020.106114
   PubMed Web of Science ®Google Scholar
• ULC CCG (2022). Molecular operating environment (MOE).
   Google Scholar
• Vassetti, D., Pagliai, M., & Procacci, P. (2019). Assessment of GAFF2 and OPLS-AA general force fields in combination with the water models TIP3P, SPCE, and OPC3 for the solvation free energy of druglike organic molecules. Journal of Chemical Theory and Computation, 15(3), 1983–1995. https://doi.org/10.1021/acs.jctc.8b01039
   PubMed Web of Science ®Google Scholar
• Wang, S.-W., & Sun, Y.-M. (2014). The IL-6/JAK/STAT3 pathway: Potential therapeutic strategies in treating colorectal cancer. International Journal of Oncology, 44(4), 1032–1040. https://doi.org/10.3892/ijo.2014.2259
   PubMed Web of Science ®Google Scholar
• Wang, X., Tang, G., Liu, Y., Zhang, L., Chen, B., Han, Y., Fu, Z., Wang, L., Hu, G., Ma, Q., Sheng, S., Wang, J., Hu, X., & Shao, S. (2022). The role of IL-6 in coronavirus, especially in COVID-19. Frontiers in Pharmacology, 13, 1033674. https://doi.org/10.3389/fphar.2022.1033674
   PubMed Web of Science ®Google Scholar
• Wang, W., Tang, J., & Wei, F. (2020). Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. Journal of Medical Virology, 92, 441–447. https://doi.org/10.1002/jmv.25689
   Google Scholar
• Wishart, D. S., Knox, C., Guo, A. C., Shrivastava, S., Hassanali, M., Stothard, P., Chang, Z., & Woolsey, J. (2006). DrugBank: A comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Research, 34(Database issue), D668–D672. https://doi.org/10.1093/nar/gkj067
   PubMed Web of Science ®Google Scholar
• Wu, D., & Yang, X. O. (2020). TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib. Journal of Microbiology, Immunology, and Infection, 53(3), 368–370. https://doi.org/10.1016/j.jmii.2020.03.005
   Web of Science ®Google Scholar
• Wu, Y., Ma, L., Zhuang, Z., Cai, S., Zhao, Z., Zhou, L., Zhang, J., Wang, P.-H., Zhao, J., & Cui, J. (2020). Main protease of SARS-CoV-2 serves as a bifunctional molecule in restricting type I interferon antiviral signaling. Signal Transduction and Targeted Therapy, 5(1), 221. https://doi.org/10.1038/s41392-020-00332-2
   PubMed Web of Science ®Google Scholar
• Zanger, U. M., &Schwab, M. (2013). Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacology & Therapeutics, 138(1), 103–141. https://doi.org/10.1016/j.pharmthera.2012.12.007 23333322
   PubMed Web of Science ®Google Scholar
• Zhang, W., Ma, Z., Wu, Y., Shi, X., Zhang, Y., Zhang, M., Zhang, M., Wang, L., & Liu, W. (2021). SARS-CoV-2 3C-like protease antagonizes interferon-beta production by facilitating the degradation of IRF3. Cytokine, 148, 155697. https://doi.org/10.1016/j.cyto.2021.155697
   PubMed Web of Science ®Google Scholar
• Zhivkova, Z. D.,Mandova, T., &Doytchinova, I. (2015). Quantitative Structure- Pharmacokinetics Relationships Analysis of Basic Drugs: Volume of Distribution. Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques, 18(3), 515–527. https://doi.org/10.18433/j3xc7s 26517139
   PubMed Web of Science ®Google Scholar
• Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin, W., & Cheng, F. (2020). Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discovery, 6, 14. https://doi.org/10.1038/s41421-020-0153-3
   PubMed Web of Science ®Google Scholar
• Zumla, A., Chan, J. F., Azhar, E. I., Hui, D. S., & Yuen, K. Y. (2016). Coronaviruses – Drug discovery and therapeutic options. Nature Reviews. Drug Discovery, 15(5), 327–347. https://doi.org/10.1038/nrd.2015.37
   PubMed Web of Science ®Google Scholar